Search

Rakesh K Sit

age ~45

from San Diego, CA

Get Report
Also known as:
  • Rakesh Kumar Sit
  • Rakash Sit
Phone and address:
9927 Paseo Montril, San Diego, CA 92129
Related to:
Connected to:

Rakesh Sit Phones & Addresses

  • 9927 Paseo Montril, San Diego, CA 92129
  • 2125 Westinghouse St, San Diego, CA 92111 • 858 874-6440
  • Reno, NV
  • 9505 Genesee Ave APT 514, San Diego, CA 92121

Work

  • Company:
    Valery v. fokin
    Sep 2009
  • Position:
    Postdoctoral research associate

Education

  • School / High School:
    University of Nevada- Reno, NV
    2004
  • Specialities:
    Ph.D. in Chemistry

Us Patents

  • Estrogen Receptor Modulators

    view source
  • US Patent:
    20210330651, Oct 28, 2021
  • Filed:
    Jul 6, 2021
  • Appl. No.:
    17/305369
  • Inventors:
    - San Diego CA, US
    Deborah Helen Slee - Encinitas CA, US
    Sayee Gajanan Hegde - San Diego CA, US
    Chad Daniel Hopkins - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Joseph Robert Pinchman - San Diego CA, US
    Rakesh Kumar Sit - San Diego CA, US
  • International Classification:
    A61K 31/438
    A61K 31/437
    A61P 5/30
    A61P 35/00
    C07B 59/00
    C07C 69/738
    C07C 69/757
    C07D 209/10
    C07D 471/04
    C07C 69/732
  • Abstract:
    Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

  • Benzamide Compounds

    view source
  • US Patent:
    20210009543, Jan 14, 2021
  • Filed:
    Jan 8, 2019
  • Appl. No.:
    16/957862
  • Inventors:
    - San Diego CA, US
    Peter Qinhua Huang - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Rakesh Kumar Sit - San Diego CA, US
    Ahmed Abdi Samatar - San Diego CA, US
  • International Classification:
    C07D 295/112
    C07D 211/46
    C07D 211/58
    C07D 295/13
    C07D 205/04
    C07D 207/12
  • Abstract:
    Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.

  • Benzamide Compounds

    view source
  • US Patent:
    20200338071, Oct 29, 2020
  • Filed:
    Jan 8, 2019
  • Appl. No.:
    16/957865
  • Inventors:
    - San Diego CA, US
    Peter Qinhua Huang - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Rakesh Kumar Sit - San Diego CA, US
    Ahmed Abdi Samatar - San Diego CA, US
  • International Classification:
    A61K 31/496
    C07D 471/04
    C07D 519/00
    A61K 31/5355
    C07D 413/12
    A61K 45/06
  • Abstract:
    Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.

  • Benzamide Compounds

    view source
  • US Patent:
    20200339605, Oct 29, 2020
  • Filed:
    Jan 8, 2019
  • Appl. No.:
    16/957861
  • Inventors:
    - San Diego CA, US
    Peter Qinhua Huang - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Rakesh Kumar Sit - San Diego CA, US
    Ahmed Abdi Samatar - San Diego CA, US
  • International Classification:
    C07D 519/00
    C07D 471/04
    C07D 241/04
    C07D 413/12
  • Abstract:
    Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.

  • Spirocyclic Compounds

    view source
  • US Patent:
    20200268714, Aug 27, 2020
  • Filed:
    Jan 6, 2020
  • Appl. No.:
    16/734857
  • Inventors:
    - San Diego CA, US
    Mehmet Kahraman - San Diego CA, US
    Deborah Helen Slee - Encinitas CA, US
    Kevin Duane Bunker - Escondido CA, US
    Chad Daniel Hopkins - San Diego CA, US
    Joseph Robert Pinchman - San Diego CA, US
    Sunny Abraham - San Diego CA, US
    Rakesh Kumar Sit - San Diego CA, US
    Daniel Lee Severance - San Diego CA, US
  • International Classification:
    A61K 31/4162
    C07D 487/10
    C07D 471/10
    A61P 35/00
    A61K 31/416
  • Abstract:
    Disclosed herein are spirocyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.

  • Estrogen Receptor Modulators

    view source
  • US Patent:
    20200261428, Aug 20, 2020
  • Filed:
    May 5, 2020
  • Appl. No.:
    16/866900
  • Inventors:
    - San Diego CA, US
    Deborah Helen Slee - Encinitas CA, US
    Sayee Gajanan Hegde - San Diego CA, US
    Chad Daniel Hopkins - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Joseph Robert Pinchman - San Diego CA, US
    Rakesh Kumar Sit - San Diego CA, US
  • International Classification:
    A61K 31/438
    C07C 69/757
    C07B 59/00
    C07D 471/04
    C07C 69/732
    C07C 69/738
    A61K 31/437
    A61P 35/00
    A61P 5/30
  • Abstract:
    Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

  • Estrogen Receptor Modulators

    view source
  • US Patent:
    20200261429, Aug 20, 2020
  • Filed:
    May 5, 2020
  • Appl. No.:
    16/866995
  • Inventors:
    - San Diego CA, US
    Deborah Helen Slee - Encinitas CA, US
    Sayee Gajanan Hegde - San Diego CA, US
    Chad Daniel Hopkins - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Joseph Robert Pinchman - San Diego CA, US
    Rakesh Kumar Sit - San Diego CA, US
  • International Classification:
    A61K 31/438
    C07C 69/757
    C07B 59/00
    C07D 471/04
    C07C 69/732
    C07C 69/738
    A61K 31/437
    A61P 35/00
    A61P 5/30
  • Abstract:
    Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

  • Estrogen Receptor Modulators

    view source
  • US Patent:
    20200261430, Aug 20, 2020
  • Filed:
    May 5, 2020
  • Appl. No.:
    16/867017
  • Inventors:
    - San Diego CA, US
    Deborah Helen Slee - Encinitas CA, US
    Sayee Gajanan Hegde - San Diego CA, US
    Chad Daniel Hopkins - San Diego CA, US
    Kevin Duane Bunker - Escondido CA, US
    Joseph Robert Pinchman - San Diego CA, US
    Rakesh Kumar Sit - San Diego CA, US
  • International Classification:
    A61K 31/438
    C07C 69/757
    C07B 59/00
    C07D 471/04
    C07C 69/732
    C07C 69/738
    A61K 31/437
    A61P 35/00
    A61P 5/30
  • Abstract:
    Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Resumes

Rakesh Sit Photo 1

Senior Scientist

view source
Location:
San Diego, CA
Industry:
Research
Work:
Kalyra Pharmaceuticals
Senior Scientist
Focus Synthesis Llc Oct 2015 - Dec 2015
Research Scientist
The Scripps Research Institute Oct 2009 - Sep 2015
Research Associate
University of Nevada Reno Aug 2004 - Aug 2009
Graduate Research Assistant
Education:
University of Nevada, Reno 2004 - 2009
Doctorates, Doctor of Philosophy, Philosophy, Chemistry Scripps Research
Skills:
Organic Chemistry
Chemistry
Organic Synthesis
Medicinal Chemistry
Drug Discovery
Nmr
Purification
Nmr Spectroscopy
Organometallic Chemistry
Fluorescence Spectroscopy
Hplc
Catalyst
Hplc Ms
Uv/Vis
Nuclear Magnetic Resonance
Pharmacokinetics
Drug Design
Mass Spectrometry
Lc Ms
Chromatography
Rakesh Sit Photo 2

Researh Associate

view source
Location:
San Diego, CA
Industry:
Research
Work:
University of Nevada Reno 2004 - 2009
Graduate Research Assistant
The Scripps Research Institute 2004 - 2009
Researh Associate
Rakesh Sit Photo 3

Rakesh Sit La Jolla, CA

view source
Work:
Valery V. Fokin

Sep 2009 to 2000
Postdoctoral Research Associate Thomas W. Bell
Reno, NV
2004 to 2009
Graduate Research Assistant under Prof Indian Institute of Technology

2001 to 2003
Education:
University of Nevada
Reno, NV
2004 to 2009
Ph.D. in Chemistry Indian Institute of Technology
Kharagpur, West Bengal
2001 to 2003
M. S. in Chemistry University of Calcutta
Kolkata, West Bengal
1998 to 2001
B. S. in Chemistry
Get Report for Rakesh K Sit from San Diego, CA, age ~45
Control profile